Reviewers play a pivotal role in the publication process by ensuring the quality, originality, and integrity of research published in the Bulletin of Pharmaceutical & Medicinal Research (BPMR). Their expertise helps provide evidence-based recommendations to editors and constructive feedback to authors, refine manuscripts and advance research in pharmaceutical and medicinal sciences.
We encourage all reviewers to consult the COPE Ethical Guidelines for Peer Reviewers to adhere to best practices and maintain ethical standards.
BPMR follows a double-anonymous peer review system, where neither the authors nor the reviewers are aware of each other’s identities.
Manuscripts are first assigned to the Editor-in-Chief (EiC), who performs an initial triage. If the manuscript passes the first threshold, it is then assigned to an Editor, who evaluates it further. The Editor then forward the manuscript to a Section Editor, who assigns the manuscript to at least two independent reviewers. The editorial team assesses the reviewers’ comments and makes a recommendation to the EiC, who makes the final decision regarding publication.
For more details on the peer review process, please visit Peer Review Process.
We understand that reviewing the manuscript can be time-consuming, and we encourage reviewers to consider their availability before accepting an invitation. If you are unable to complete the review within the allocated timeframe, please decline promptly and, if possible, suggest alternative reviewers to avoid delays in the review process.
Reviewers are expected to submit their reports and recommendations within seven (07) days of accepting the invitation to review. If you anticipate a delay in submitting your review, please email the Editorial Office who may be able to extend your deadline.
Before you accept or decline an invitation to review, consider the following:
For further guidance on the peer review process, we encourage reviewers to explore valuable resources from the Committee on Publication Ethics (COPE).
When beginning your review, thoroughly read the manuscript while keeping a blank document or paper handy for notes. Number your observations to clearly reference specific sections in your review report.
After completing your initial reading, focus on assessing the main text critically, applying the same rigor as you would when evaluating a scientific paper. To guide your evaluation, consider the following questions:
Once you have thoroughly read the manuscript, review the abstract to ensure that the authors' claims and statements align accurately with the content and findings of the manuscript.
After evaluating each section of the manuscript, take a step back and assess the study as a whole. Consider its overall relevance, novelty, structure, and compliance with ethical and reporting standards. Use the following questions to guide your evaluation:
For certain types of original research, authors are required to follow established reporting guidelines and submit the relevant checklist to ensure transparency and reproducibility. The following checklists may assist you during your review:
Clinical Practice Guidelines | AGREE |
Animal Experiments | ARRIVE |
Case Reports | CARE |
Economics Evaluations | CHEERS |
Randomized Controlled Trials | CONSORT |
Systematic Review and Meta-Analyses | PRISMA |
Quality Improvement Studies | SQUIRE |
Diagnostic Accuracy Studies | STARD |
Qualitative Studies | SRQR |
Genetic Association Studies | STREGA |
Observational Studies | STROBE |
Non-Randomized Trials | TREND |
Multivariable Prediction Models | TRIPOD |
Routinely Collected Health Data | RECORD |
Quantitative PCR Data | MIQE |
Core Outcome Set Development Study Protocol | COS-STAP |
We encourage reviewers to reflect on whether the manuscript sufficiently incorporates EDI in its research and evaluation processes. Where appropriate, please provide comments on EDI considerations, guided by the following questions:
When writing your review, keep the following in mind:
In the confidential comments section, provide a detailed evaluation of the manuscript for the editorial team. These comments are not shared with the authors and should include the following:
When providing comments to the authors:
When making a recommendation, consider the categories typically used by the editor to classify the manuscript:
The authors are required to submit a detailed list of changes made in response to reviewer comments, along with any necessary clarifications or explanations. Minor revisions may be assessed by the editor, whereas major revisions are typically returned to the original reviewers for further evaluation, if available.
As a reviewer, your role in the revision process is to determine whether the authors have adequately addressed the concerns raised during the initial review and assess if the revised manuscript meets publication standards. When evaluating revisions:
Are you interested in becoming a reviewer for BPMR or other journals in the Logixs Journals portfolio?
Select the journals you wish to review for from the multiple-selection dropdown list featuring all journals in the publisher’s portfolio.
Once your application is submitted, the publisher’s staff will review your profile. Upon approval by the journal’s executive board, your name will be added to the reviewer database, making your profile visible to the editorial team.
We look forward to welcoming you to our reviewer team!